Previous 10 |
Legacy Reserves (NASDAQ: LGCY ) -32% after announcing review of strategic alternatives. More news on: Legacy Reserves Inc., Tailored Brands, Inc., Build-A-Bear Workshop, Inc., Stocks on the move, Read more ...
VivoPower International (NASDAQ: VVPR ) -21% . More news on: VivoPower International PLC, Navios Maritime Holdings Inc., Express, Inc., Stocks on the move, Read more ...
WATERTOWN, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and other diseases, today announced that Kathryn Gregory has been named Chief Business Officer (CBO). In th...
Gainers: MacroGenics (NASDAQ: MGNX ) +129% . Snap (NYSE: SNAP ) +24% . Jason Industries (NASDAQ: JASN ) +23% . Bionano Genomics (NASDAQ: BNGO ) +16% . Proteostasis Therapeutics (NASDAQ: PTI ) +16% . Plantronics (NYSE: PLT ) +15% . Neon Therapeutics (NASDAQ: NTGN ) +15% . MaxLi...
Gainers: Amyris (NASDAQ: AMRS ) +43% . TMSR Holding (NASDAQ: TMSR ) +20% . Trevena (NASDAQ: TRVN ) +20% . Jason Industries (NASDAQ: JASN ) +17% . Evolus (NASDAQ: EOLS ) +16% . Urban One (NASDAQ: UONE ) +3% . Payment Data Systems (NASDAQ: PYDS ) +15% . Aileron Therapeutics (NAS...
CORAL GABLES, FL / ACCESSWIRE / February 1, 2019 / The healthcare stock market's success is largely dependent on the fact that, as the global population increases, more people will fall prey to illnesses and ailments, and in turn, these individuals will need access to qualitative, effectiv...
Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%. Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%. Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...
News, Short Squeeze, Breakout and More Instantly...
Aileron Therapeutics Inc. Company Name:
ALRN Stock Symbol:
NASDAQ Market:
Aileron Therapeutics Inc. Website:
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference PR Newswire AUSTIN, Texas , July 30, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first...
Aileron Therapeutics to be Included in the Russell Microcap® Index PR Newswire AUSTIN, Texas , July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of...
Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated Topline results from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) expected in ...